-
Company Insights
New![]()
Innovation and Patenting activity of CSC Financial Co Ltd Q3 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of CSC Financial Co Ltd Q3 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Ezurpimtrostat in Bile Duct Cancer (Cholangiocarcinoma)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Ezurpimtrostat in Bile Duct Cancer (Cholangiocarcinoma) Drug Details:Ezurpimtrostat (GNS-561) is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Ezurpimtrostat in Metastatic Hepatocellular Carcinoma (HCC)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Ezurpimtrostat in Metastatic Hepatocellular Carcinoma (HCC) Drug Details: Ezurpimtrostat (GNS-561) is under development for the...
-
Product Insights
![]()
CSC – Waterside Town Center Mixed-Use Development – Virginia
Equip yourself with the essential tools needed to make informed and profitable decisions with our CSC - Waterside Town Center Mixed-Use Development - Virginia report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into...
-
Product Insights
![]()
CSC Land/ Frasers Property – Parc Greenwich – Central Singapore
Equip yourself with the essential tools needed to make informed and profitable decisions with our CSC Land/ Frasers Property - Parc Greenwich - Central Singapore report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...
-
Product Insights
![]()
China Overseas/ CSC Land – Verdale Condominium – Central Singapore
Equip yourself with the essential tools needed to make informed and profitable decisions with our China Overseas/ CSC Land - Verdale Condominium - Central Singapore report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...
-
Product Insights
![]()
CSC El Campin – El Campin Stadium Mixed-Use Urban Renovation – Bogota D.C.
Equip yourself with the essential tools needed to make informed and profitable decisions with our CSC El Campin - El Campin Stadium Mixed-Use Urban Renovation - Bogota D.C. report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full...
-
Company Profile
![]()
Carlsberg AS – Company Profile
Carlsberg AS (Carlsberg) is a producer and marketer of alcoholic and non-alcoholic beverages. Its product portfolio includes beers, alcohol-free beers, pilsner, lagers and ciders. It also offers energy drinks, fruit beers, juices, low alcohol and ready-to-drink products, soft drinks, and water. The company markets these products under various brands such as Carlsberg, Astra, Angkor, Warteck, Kronenbourg, Ringnes, Dali, 1664 Blanc, Grimbergen, Baltika, Somersby, Holsten, Tuborg, Wusu, among others. It also conducts its procurement, production, logistics and planning functions through its...
Add to Basket -
Sector Analysis
![]()
Switzerland Construction Market Size, Trend Analysis by Sector, Competitive Landscape and Forecast to 2027
Switzerland Construction Market Report Overview The Switzerland construction market size was $93.6 billion in 2022. The market is projected to achieve an AAGR of more than 1% during 2024-2027, supported by investments in transport and renewable energy infrastructure projects. Switzerland Construction Market Outlook, 2022-2027 For more insights into the Switzerland construction market forecast, download a free report sample The Switzerland construction market research report provides detailed market analysis, information, and insights into the Switzerland construction industry, including the growth prospects...
-
Company Profile
![]()
Medicenna Therapeutics Corp – Company Profile
Medicenna Therapeutics Corp (Medicenna), formerly A2 Acquisition Corp, is a clinical stage immuno-oncology company developing empowered cytokines (EC) and first-in-class, Interleukins (IL-2, IL-4 and IL-13) superkines for the treatment of cancer. The company's pipeline products include MDNA55, IL-4 cytokine for recurrent glioblastoma and other brain and non-brain tumors, MDNA57, targeting solid tumors and non-malignant cells, MDNA109, an IL-2 agonist to treat cancer immunotherapies, MDNA209, an IL-2 antagonist for autoimmune diseases, MDNA413, a dual IL-4/IL-13 antagonist for the treatment of solid...
Add to Basket
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.